M

Researcher Profile

Marcelo Kugelmas

3

Publications

1,176

Citations

10

Co-Authors

3

Active Years

Publications

Journal Article Journal of Hepatology May 01, 2025

OS-089 Elafibranor for primary sclerosing cholangitis: the ELMWOOD phase II randomised controlled trial

Cynthia Levy · George Abouda · Bahri Bilir · Alan Bonder +38 more

10.1016/s0168-8278(25)00404-0 3 citations

Journal Article Clinical Gastroenterology and Hepatology Oct 01, 2022

Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry

Zobair M. Younossi · Yusuf Yilmaz · Ming-Lung Yu · Vincent Wai-Sun Wong +27 more

10.1016/j.cgh.2021.11.004 90 citations

Journal Article The Lancet Dec 01, 2019

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M Younossi · Vlad Ratziu · Rohit Loomba · Mary Rinella +365 more

10.1016/s0140-6736(19)33041-7 1,083 citations

Publication Timeline

2025

1

2022

1

2019

1

Frequent Co-Authors

Manuel Romero-Gomez

Antonio Olveira

Elisabetta Bugianesi

Helena Cortez-Pinto

Mitchell Shiffman

Aldo Montano-Loza

Alonzo Williams A